Experience

Davis Polk is advising Advanced Semiconductor Engineering, Inc. in connection with its tender offers in the Republic of China and the United States for common shares and American depositary…

Davis Polk represents various subsidiaries of Comcast Corp. in four patent infringement lawsuits against Sprint Communications Co. LP pending in federal courts across the country. On August…

Davis Polk advised the underwriter in connection with a concurrent SEC-registered Schedule B debt offering by KEXIM of US$125 million aggregate principal amount of its floating-rate notes…

Davis Polk advised C1 Financial, Inc. (“C1”) and the selling stockholders in connection with the $21.7 million SEC-registered secondary offering of 1,256,255 shares of common stock of C1 by…

Davis Polk is advising SS&C Technologies Holdings, Inc. in connection with its acquisition of Citigroup’s Alternative Investor Services business, which includes Hedge Fund Services and…

Davis Polk advised the joint book-running managers in connection with the $138 million initial public offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock…

Davis Polk advised MSCI Inc. (“MSCI”) in connection with a Rule 144A/Regulation S offering of $800 million aggregate principal amount of its 5.750% senior notes due 2025. The notes are…

Davis Polk advised CAR Inc. in connection its Regulation S offering of $300 million 6.00% senior notes due 2021. The notes are guaranteed by certain offshore subsidiaries of CAR Inc…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Celgene Corporation of $8.0 billion aggregate principal amount of notes. The notes were issued in…

Davis Polk advised the underwriters in connection with the $183.9 million initial public offering of Aimmune Technologies, Inc. Aimmune Therapeutics sold 11,499,999 shares of its…